Zyversa therapeutics announces publication demonstrating that inflammasome asc inhibitor ic 100 restored retinal structure and function in a retinopathy of prematurity animal model

Publication showed that ic 100 suppressed retinal microglia activation by interfering with asc speck formation, attenuating retinal inflammation, abnormal retinal vascularization, and retinal thinning, and it led to restored retinal function. retinopathy of prematurity (rop), affecting very low birth weight premature infants is a leading cause of childhood blindness worldwide.
ASC Ratings Summary
ASC Quant Ranking